Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease | Patent Publication Number 20180064671

US 20180064671 A1
Patent NumberUS 10912751 B2
Application Number15558084
Filled DateMar 14, 2016
Priority DateMar 13, 2015
Publication DateMar 8, 2018
Original AssigneeEsperion Therapeutics Inc.
Current AssigneeEsperion Therapeutics Inc.
Inventor/ApplicantsDiane Elaine MacDougall
Roger Schofield Newton
Noah Laban Rosenberg
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.